Brain/Neural Hand Exoskeleton Control for Restoration of Bimanual Tasks
NCT ID: NCT04440709
Last Updated: 2020-06-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
10 participants
INTERVENTIONAL
2020-06-30
2020-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Moving a Paralyzed Hand Through Use of a Brain-Computer Interface
NCT00242242
BCI Driving FES and Hand Orthosis for Upper Limb Rehabilitation in Chronic Stroke
NCT06179745
Motor Imagery BCI Rehabilitation After Stroke
NCT04847089
Restoring High Dimensional Hand Function to Persons With Chronic High Tetraplegia
NCT03482310
Efficacy of Hand Exoskeleton Controlled by BCI in Post Stroke Patients
NCT02325947
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Brain/neural hand exoskeleton (B/NHE)
Brain/neural hand exoskeleton (B/NHE)
The brain/neural hand exoskeleton restores hand motor function by translating user's intention into grasping motions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Brain/neural hand exoskeleton (B/NHE)
The brain/neural hand exoskeleton restores hand motor function by translating user's intention into grasping motions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* interval since stroke at least 6 months
* substantial motor deficit with:
* Medical Research Council (MRC) -score of less than 2 out of 6 possible points (0=no activity; 1=visible contraction without motor effect; 2=movements with elimination of gravity; 3=movements against gravity; 4=movements against weak resistance; 5=normal force)
* Fugl-Meyer Test (upper extremity) of less than 31 points, "no to little mobility"
* cervical spinal cord injury, height C5-C6
* interval after spinal cord injury at least 6 months
* substantial motor deficit with American Spinal Cord Association (ASIA) -Classification B or C (A=no muscle function/sensitivity below the spinal cord injury; B=no muscle function, limited sensitivity present; C=low non-relevant muscle function, sensitivity present; D=functionally relevant muscle functions present; E=fully preserved or restored functions)
Exclusion Criteria
* currently undergoing neurological or psychiatric treatment based on a secondary diagnosis
* Severe and uncontrollable medical problems:
* Non-adjusted malignant high blood pressure, World Health Organization (WHO) Hypertension Grade II
* non-adjustable diabetes mellitus, HbA1c \> 58 mmol/mol
* renal failure, from KDIGO glomerular filtration rate (GFR) category G3b (moderate to severe impairment)
* Liver failure, Child-Pugh stages B and C
* Heart failure New York Heart Association (NYHA) grade III-IV
* malignant tumor disease
* severe arrhythmia in need of treatment
* severe oedemas
* severe arthritis
* serious cognitive impairment (minimum status below 23 points)
* Severe spasticity (Ashworth grade ≥ 4)
* Pregnancy
* Bilateral motor deficit (in stroke patients)
18 Years
68 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Reutlingen University
UNKNOWN
Hochschule der Medien
UNKNOWN
University of Stuttgart
OTHER
University Hospital Tuebingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Tuebingen
Tübingen, Baden-Wurttemberg, Germany
Charité - University Medicine Berlin
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NEU007/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.